E- ISSN: 2320 - 3528
P- ISSN: 2347 - 2286

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Biosynthesis of Glucaric Acid with Microbial Cell Factories

Zhen Kang* and Xu Gong

The Key Laboratory of Industrial Biotechnology, Ministry of Education, Jiangnan University, Wuxi 214122, P. R. China

*Corresponding Author:
Zhen Kang
The Key Laboratory of Industrial Biotechnology, Ministry of Education
Jiangnan University, Wuxi 214122, P. R. China
E-mail: zkang@jiangnan.edu.cn

Received date: 13/10/2016; Accepted date: 20/12/2016; Published date: 26/12/2016

Visit for more related articles at Research & Reviews: Journal of Microbiology and Biotechnology

Abstract

Glucaric acid is a kind of organic acid and widely used in food, medicine and chemical industries. During the past decade, model microorganisms such as Escherichia coli and Saccharomyces cerevisiae have been engineered for production of glucaric acid. Especially, Pichia pastoris has also been engineered for production of glucaric acid with the highest reported value. In this commentary, recent efforts and advances for glucaric acid biosynthesis were discussed

Abstract

Glucaric acid is a kind of organic acid and widely used in food, medicine and chemical industries. During the past decade, model microorganisms such as Escherichia coli and Saccharomyces cerevisiae have been engineered for production of glucaric acid. Especially, Pichia pastoris has also been engineered for production of glucaric acid with the highest reported value. In this commentary, recent efforts and advances for glucaric acid biosynthesis were discussed.

Keywords

Glucaric acid, Microbial cell factories, Pichia pastoris

Introduction

Glucaric acid, a natural, high valuable organic acid, has been characterized as a “top value-added chemical” from biomass because of its various applications [1]. Due to the drawbacks of traditional chemical methods, production of glucaric acid with microbial cell factories as a potential clean and environmentally-friendly approach has attracted much attention [2,3]. Many efforts have been devoted to construct robust cell factories for glucaric acid biosynthesis [4-6]. Naturally, glucaric acid can be synthesized in mammalian and plant cells. However, the biosynthesis pathway is long and not fully recognized [7]. Thus, a short biosynthetic pathway from glucose or myo-inositol was designed and characterized. In 2009, Moon et al. firstly recruited the myo-inositol-1- phosphate synthase encoding gene INO1 from Saccharomyces cerevisiae, and the myo-inositol oxygenase encoding gene mMIOX from mouse and the urinate dehydrogenase encoding gene udh from Pseudomonas syringae and constructed a novel glucaric acid biosynthesis pathway in Escherichia coli [6]. Although glucaric acid was detected in cultures (about 1 g/L), the intermediates myo-inositol and glucuronic acid were accumulated because of the low activity of MIOX. Thus, improvement the stability and activity of MIOX is crucial for optimizing the flux towards glucaric acid. In this regard, the researchers from Prather group tried different strategies including directed evolution, synthetic scaffolds and fusion tags to increase the activity of MIOX to balance the flux towards glucaric acid [8,9]. As a result, 4.85 g/L glucaric acid was achieved from 10.8 g/L myo-inositol. However, the production failed to increase after further modifying pathways and optimizing feeding of supplemental carbon sources [10-12]. The results from E. coli suggested that achievement of high level expression of the rate-limiting MIOX and improvement of the tolerance towards pH-mediated toxicity should be the key points for high titer of glucaric acid. To this end, Saccharomyces cerevisiae was also investigated for production of glucaric acid because of its satisfactory acid-tolerance [4]. Accordingly, the constructed glucaric acid biosynthetic pathway in E. coli was ported into S. cerevisiae with codon-optimized MIOX. Applying a fed-batch fermentation strategy, the production was increased to 1.6 g/L from glucose supplemented with myo-inositol. The results indicated that pHmediated toxicity is not an essential issue for E. coli.

In addition to E. coli and S. cerevisiae, the methylotrophic yeast Pichia pastoris (now reclassified as Komagataella phaffii), has also been widely used for production of heterologous proteins and valuable chemicals because of its many advantages, for instance, the ability to grow to high cell densities in simple media and the GRAS (generally recognizedas safe) status [13,14]. In particular, it has been demonstrated that P. pastoris possesses excellent performance in functional expression of cytochrome P450 related oxygenases [15-17]. Additionally, expression of the final enzyme Udh of the glucaric acid synthetic pathway is compatible with cell growth since Udh is thermally unstable and displays high activity at 30°C. In consideration of these points, P. pastoris should be a suitable candidate for production of glucaric acid. For this reason, Liu et al. firstly investigated and functionally validated an endogenous MIOX, and then successfully constructed the glucaric acid biosynthesis pathway in P. pastoris [5]. After optimization of the expression of MIOX and Udh with a fusion expression strategy, and applying a fed-batch approach, the titer of glucaric acid was significantly increased to 6.61 g/L from glucose and myo-inositol. Compared with E.coli and S. cerevisiae, P. pastoris was much more appropriate and efficient for glucaric acid production. In addition, it could be found that in addition to the low activity of MIOX, the inefficient biosynthesis of myo-inositol is also a bottleneck for high level production of glucaric acid from glucose. Additionally, myo-inositol also serves as an essential precursor for synthesis of phosphatidyliositol, which plays an important role in signaling and lipid synthesis. Therefore, future efforts for P. pastoris should be focused on (I) engineer and overexpression of the upstream genes, especially INO1 for myo-inositol biosynthesis; (II) modification and improvement of MIOX expression and activity with inducible promoters; (III) knock-down of the competing essential pathway flux; (IV) exploration and construction of novel synthetic pathways towards glucaric acid (Figure 1).

microbiology-biotechnology-Potential-pathways

Figure 1: Potential pathways for glucaric acid biosynthesis. The dash lines means the corresponding enzymes are not identified or characterized.

Conclusion

Pichia pastoris is a desirable host for glucaric acid biosynthesis. With the development of synthetic biology toolboxes and metabolic engineering strategies, the intact glucaric acid biosynthesis pathway from glucose could be systematically engineered and optimized in the context of global regulation. By combining cost effective fermentation strategies, efficient processes for production of glucaric acid from glucose should be established in near future.

References